Henry Freudenstein

机构：University Hospital Magdeburg, Otto-von-Guericke-Universität Magdeburg

发表论文 4 篇 · 总被引 6 次 · h-index 2

代表论文

• Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity (2025 · Molecular Oncology · 被引 3)
• ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma (2025 · Scientific Reports · 被引 3)
• Patient-Specific Pharmacogenomics unveils xCT as a Key Regulator for Druggable Metabolic and Proliferation Pathways in Colon Cancer (2025 · bioRxiv (Cold Spring Harbor Laboratory))
• ZEB1 als Biomarker für effiziente Kombinationstherapie in Hepatozellulärem Karzinom (2024 · Zeitschrift für Gastroenterologie)